RE:Poor Results If you factor out the one time expansion related costs in NJ & Md & the rectified PA product recall, the results look more like a wash with all of the upside sales growth expectations to factor in for 22Q2-Q4 and beyond. During the conference Wild and the other management members explained these Q1 sped bumps while at the same time expressing their excitement going forward as an industry leader with lots of additional accreative prospects to consider. With this outlook, picking up a couple of thousand shares at the end of the day seems like a gift to me. Thanks and GLTAlongs